Marine Drugs

Marine Drugs is an open-access journal published monthly by MDPI since 2003, covering the discovery, development and production of biologically and therapeutically active compounds from marine organisms, with a 2025 Journal Impact Factor of 5.7.《海洋药物》（Marine Drugs）由（MDPI）出版，2003 年创刊，按月在线出版，覆盖海洋生物活性与治疗活性化合物的发现、开发与生产，2025 年期刊影响因子为 5.7。

Scope

• Bioactive compounds are identified from marine microorganisms, invertebrates, fishes and plants, including algae, seagrasses and mangroves.活性化合物来源涵盖海洋微生物、无脊椎动物、鱼类与植物，包括藻类、海草与红树林。
• Pharmacological characterisation of marine compounds and their derivatives is a core activity, as is the study of natural products active against human, animal and plant diseases.海洋化合物及其衍生物的药理学表征是核心工作，针对人、动物与植物病害的活性天然产物研究同样如此。
• Insecticidal and herbicidal activities of marine natural products are also within scope.海洋天然产物的杀虫与除草活性亦在收稿范围。
• Synthesis, mutasynthesis and medicinal chemistry of marine natural products are covered, together with proteomic, glycomic and lipidomic work tied to bioactivity.海洋天然产物的合成、突变合成与药物化学均在覆盖之内，与活性相关的蛋白质组、糖组与脂质组研究亦然。
• Drug development is followed through pharmaceutical formulation and clinical trials.药物开发一路跟踪到制剂与临床试验环节。
• Marine chemical ecology, innovative sampling and isolation techniques, and biotechnology or molecular biology aimed at drug discovery and production are welcomed.海洋化学生态学、新的采样与分离技术，以及面向药物发现与生产的生物技术和分子生物学均受欢迎。
• Structural and biological characterisation of marine toxins, biomaterials of marine origin, and ingredients for cosmeceuticals, nutraceuticals and functional foods complete the scope.海洋毒素的结构与生物学表征、海洋来源生物材料，以及药妆、营养保健品与功能食品用原料补足了收稿范围。

History

• The journal was founded in 2003 by MDPI in Basel, with Hua-Shi Guan as its first editor-in-chief.本刊于 2003 年由总部设于巴塞尔的（MDPI）创办，管华诗出任首任主编。
• Editors-in-chief have since changed several times, from Hua-Shi Guan to Peter Proksch, Hartmut Laatsch, Alejandro M. S. Mayer, Orazio Taglialatela-Scafati and, from 2022, Bill J. Baker.主编此后数次更替，由管华诗而 Peter Proksch、Hartmut Laatsch、Alejandro M. S. Mayer、Orazio Taglialatela-Scafati，2022 年起为 Bill J. Baker。
• The year 2023 marked the twentieth anniversary of the title, which has appeared monthly online since its launch.2023 年为本刊创刊二十周年，自创办起即按月在线出版。
• It has been fully open access from the outset, with article processing charges paid by authors or their institutions and copyright retained by the authors under a CC BY licence.本刊自始即为完全开放获取，文章处理费由作者或其机构承担，著作权按（CC BY）许可归作者所有。
• Articles carry no length limit, and publication is continuous, with each paper identified by an article number rather than a page range.论文不设篇幅上限，采用连续出版，每篇以文章编号而非页码区间标识。
• The 2025 Journal Impact Factor is 5.7, after 5.4 in 2024, 6.085 in 2022 and 5.118 in 2021, and the 2025 CiteScore is 11.6.2025 年期刊影响因子为 5.7，2024 年为 5.4，2022 年为 6.085，2021 年为 5.118，2025 年 CiteScore 为 11.6。

Editors

• Bill J. Baker, professor in the Department of Chemistry at the University of South Florida, has been editor-in-chief since 2022 and works on chemical ecology, biosynthesis and genome mining of marine invertebrates and algae.南佛罗里达大学化学系教授 Bill J. Baker 自 2022 年起任主编，研究海洋无脊椎动物与藻类的化学生态、生物合成与基因组挖掘。
• Baker took his doctorate with Paul Scheuer in Hawaii and has spent three decades on Antarctic organisms and, more recently, deep-sea invertebrates from the Irish continental margin.Baker 在夏威夷师从 Paul Scheuer 取得博士学位，三十年来研究南极生物，近年转向爱尔兰大陆边缘的深海无脊椎动物。
• Eight section editors lead the subject sections: Anake Kijjoa, Marc Diederich, Andrew Turner, Hermann Ehrlich, Ipek Kurtboke, Vassilios Roussis, Yue-Wei Guo and Marialuisa Menna.八个学科栏目由 Anake Kijjoa、Marc Diederich、Andrew Turner、Hermann Ehrlich、Ipek Kurtboke、Vassilios Roussis、郭跃伟与 Marialuisa Menna 分任栏目主编。
• Their bases run from Porto, Seoul, Weymouth, Poznan, Queensland and Athens to the Shanghai Institute of Materia Medica and the University of Naples Federico II.其所在机构从波尔图、首尔、韦茅斯、波兹南、昆士兰与雅典，一直到上海药物研究所与那不勒斯费德里科二世大学。
• Associate editors include Hitoshi Sashiwa of Kaneka and Claudiu Supuran of the University of Florence, and the board is drawn mainly from Europe, China, the United States and Japan.副编辑包括（Kaneka）的 Hitoshi Sashiwa 与佛罗伦萨大学的 Claudiu Supuran，编委主要来自欧洲、中国、美国与日本。
• Median time to first decision was 14.2 days in the first half of 2026, with 2.8 days from acceptance to publication, and the journal is affiliated with the Australia New Zealand Marine Biotechnology Society.2026 年上半年首次决定的中位时间为 14.2 天，录用到出版为 2.8 天，本刊并与（Australia New Zealand Marine Biotechnology Society）建立会刊关系。